Inventor · disambiguated record
Ashique Rafique
Also filed as: RAFIQUE ASHIQUE
19 granted patents·11 pending applications·900 citations·filing 2007–2025
96Inventor score
Top patents by PatentIndex Score
30 records- 0199US8043617B2Human antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2009·Granted Oct 25, 2011·91 cites·9 claims
- 0299US7582298B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2007·Granted Sep 1, 2009·390 cites·7 claims
- 0397US10179819B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2016·Granted Jan 15, 2019·25 cites·12 claims
- 0497US7605237B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2007·Granted Oct 20, 2009·194 cites·6 claims
- 0596US9884916B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2016·Granted Feb 6, 2018·13 cites·7 claims
- 0695US11155633B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2018·Granted Oct 26, 2021·9 cites·24 claims
- 0794US8338135B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2011·Granted Dec 25, 2012·33 cites·12 claims
- 0894US8192741B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2011·Granted Jun 5, 2012·22 cites·10 claims
- 0994US8092802B2High affinity human antibodies to human IL-4 receptorSTEVENS SEAN·Filed 2010·Granted Jan 10, 2012·33 cites·4 claims
- 1094US7794717B2High affinity human antibodies to human IL-4 receptorREGENERON PHARMA·Filed 2009·Granted Sep 14, 2010·34 cites·4 claims
- 1193US8568721B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2012·Granted Oct 29, 2013·18 cites·9 claims
- 1293US2025206829A1High affinity antibodies to human il-6 receptorREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1392US8183014B2High affinity antibodies to human IL-6 receptorSTEVENS SEAN·Filed 2011·Granted May 22, 2012·11 cites·19 claims
- 1491US9308256B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyREGENERON PHARMA·Filed 2013·Granted Apr 12, 2016·11 cites·14 claims
- 1591US8080248B2Method of treating rheumatoid arthritis with an IL-6R antibodyRADIN ALLEN·Filed 2010·Granted Dec 20, 2011·15 cites·11 claims
- 1689US2025340672A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1786US11370843B2High affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·15 claims
- 1886US2024124613A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1983US2023094591A1High affinity antibodies to human il-6 receptorREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 2081US2025282891A1Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2176US12344677B2Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereofREGENERON PHARMA·Filed 2021·Granted Jul 1, 2025·0 cites·28 claims
- 2272US10584173B2Nucleic acids encoding high affinity antibodies to human IL-6 receptorREGENERON PHARMA·Filed 2018·Granted Mar 10, 2020·0 cites·15 claims
- 2372US2020377618A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 2470US10787522B2VL antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2018·Granted Sep 29, 2020·0 cites·20 claims
- 2569US12325752B2Immunoglobulin proteins that bind to NPR1 agonistsREGENERON PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·44 claims
- 2667US2014255995A1High affinity antibodies to human il-6 receptorREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 2765US2025333524A1Immunoglobulin proteins that bind to npr1 agonistsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 2863US2013157313A1High affinity antibodies to human il-6 receptorSTEVENS SEAN·Filed 2012·Application pending·0 cites
- 2959US2015266976A1Vl antigen binding proteins exhibiting distinct binding characteristicsREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 3048US2025276092A1Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody responseREGENERON PHARMA·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →